NICK G. SITCHON,CINDY MESTON,MOLLY KATZ,LEONARD DROGATIS,ROBERT TAYLOR SEGRAVES,ANITA CLAYTON,ROBERT E. PYKE
申请号：
ARP160101856
公开号：
AR105087A1
申请日:
2016.06.21
申请国别(地区):
AR
年份:
2017
代理人:
摘要：
Methods for the treatment of Women with Hypoactive Sexual Desire Disorder (HSDD) with daily oral treatment combinations of low dose and high dose of trazodone and bupropion.Claim 1: a method of treatment of Women with HSDD with Combination Therapy that includes at least two different Drugs, where women are in need of a treatment for HSDD, wherein Said method comprises: (a) The Daily Administration to the wife of a P Rimer Drug which has a concentration of 150 mg doseWhere is the first Drug Bupropion Daily Administration； (b) Women a Second Drug which has a concentration of 75 mg dose, where the second Drug Is trazodone； and (c) where the Administration of said first and said Second Drug is a drug According to a prescribed Treatment regimen for the treatment of Women for HSDD.Claim 2: the method of claim 1, wherein said treatment regimen prescribed by approximately one or more months. Claim 6: the method of claim 1, wherein said treatment regimen prescribed by approximately one year or more.Claim 7: the method of claim 1, wherein the Bupropion is in a sustained release dosage form or extended. Claim 8: the method of claim 1, wherein the trazodone is a sustained release dosage form or extended.Claim 36: the use of trazodone and Bupropion in the manufacture of a Medicament for the treatment of Hypoactive Sexual Desire Disorder (HSDD), where trazodone is a quantity of approximately 75 mg, pharmaceutically acceptable Salts and their esters, HID Times, solvates or isomers, prodrugs thereof,And Bupropion is a quantity of approximately 150 mg, and any pharmaceutically acceptable salts, esters, hydrates, solvates and prodrugs thereof, isomer, where the drug is to be administered by the oral Route, and where treatment is to be continued and Journal According to a prescribed Treatment regimen.Métodos de tratamiento de mujeres para el Trastorno del Deseo Sexual Hipoactivo (HSDD) con tratamientos diarios orales de combinaciones de bajas dosis y altas dosis de trazodona y bupropi
